The Technical Analyst
Select Language :
Terns Pharmaceuticals, [TERN]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Terns Pharmaceuticals, Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Terns Pharmaceuticals, is listed at the  Exchange

6.49% $6.56

America/New_York / 28 mar 2024 @ 16:00


Terns Pharmaceuticals,: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 424.12 mill
EPS: -1.270
P/E: -5.17
Earnings Date: May 12, 2024
SharesOutstanding: 64.65 mill
Avg Daily Volume: 0.824 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Neutral
DE: Sell
P/E: Strong Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -5.17 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.88x
Company: PE -5.17 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$1.113
(-83.03%) $-5.45
Date: 2024-03-28
Expected Trading Range (DAY)

$ 5.87 - 7.25

( +/- 10.46%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-10 Kuriakose Emil Sell 0 Common Stock
2024-03-10 Kuriakose Emil Sell 280 000 Stock Option (Right to buy)
2024-03-10 Kuriakose Emil Sell 117 500 Stock Option (Right to buy)
2024-03-01 Burroughs Amy L. Buy 1 250 000 Stock Option (Right to buy)
2024-03-01 Burroughs Amy L. Buy 150 000 Restricted Stock Unit
INSIDER POWER
78.48
Last 96 transactions
Buy: 30 047 425 | Sell: 4 951 891

Forecast: 16:00 - $7.67

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $7.67
Forecast 2: 16:00 - $7.67
Forecast 3: 16:00 - $7.67
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $6.56 (6.49% )
Volume 1.217 mill
Avg. Vol. 0.824 mill
% of Avg. Vol 147.71 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Terns Pharmaceuticals, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for Terns Pharmaceuticals, Inc.

RSI

Intraday RSI14 chart for Terns Pharmaceuticals, Inc.

Last 10 Buy & Sell Signals For TERN

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$6.21N/AActive
Profile picture for
            Terns Pharmaceuticals, Inc.

TERN

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical trial for the treatment of NASH; and TERN-201, a vascular adhesion protein-1 inhibitor that is in Phase Ib clinical trial for the treatment of NASH. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase I clinical trial for the treatment of NASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for NASH and metabolic diseases, such as obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.

Last 10 Buy Signals

Date Signal @
FOLDUSDMar 28 - 16:0320.73
SSVUSDMar 28 - 15:5959.98
SNXUSDMar 28 - 16:00$4.88
ROUTEUSDMar 28 - 15:594.17
FORTHUSDMar 28 - 16:006.60
BCHUSDMar 28 - 16:00$570.06
SFPUSDMar 28 - 15:53$0.773
TAOUSDMar 28 - 15:54545.52
JAZZMar 28 - 15:55$120.49
CTXCUSDMar 28 - 15:54$0.485

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.